POK: Computer-assisted diagnostic software for lesions suspicious for cancer

Product code POK covers computer-assisted diagnostic software for lesions suspicious for cancer, Class II devices regulated under 21 CFR 892.2060 and reviewed by FDA's Radiology panel. FDA's 510(k) database lists 24 clearances under POK.
Updated Oct 23, 2026 · Clearances from FDA’s 510(k) database, as of Nov 16, 2026
Product code
POK
Regulation
21 CFR 892.2060
Class
II
Panel
Radiology
Clearances
24
Most recent
Oct 23, 2026
Median review, last 2 years
116 days

What it covers

Prescription image processing software that helps users characterize lesions already identified on images such as MR, mammography, radiography or CT as suspicious for cancer. Diagnostic and patient management decisions are made by the clinical user.

Recent clearances

510(k)DeviceApplicantDecisionType
K261679BlineSlideDeep Breathe, Inc.Oct 23, 2026Traditional
K253884Koios DS (3.8)Koios Medical, Inc.Jul 2, 2026Traditional
K261519Sonio SuspectSonioJun 4, 2026Special
K254161Automated Aortic Stenosis Software (AutoAS)GE Medical Systems Ultrasound & Primary Care Diagnostics, LLCMar 27, 2026Traditional
K251769RevealAI-LungPrecision Medical Ventures, Inc. Dba RevealdxJan 30, 2026Traditional
K252294Fetal EchoScan (v1.2)BrightheartDec 8, 2025Traditional
K250221StrokeSENS ASPECTS Software ApplicationCircle Cardiovascular Imaging, Inc.Jul 1, 2025Traditional
K251071Fetal EchoScan (v1.1)BrightheartMay 2, 2025Special
K243614Sonio SuspectSonioFeb 21, 2025Traditional
K243294Brainomix 360 e-ASPECTSBrainomix LimitedFeb 14, 2025Traditional
From FDA’s 510(k) database, as of Nov 16, 2026Export CSV (100 rows free · all 24 with a free account)

Clearances by year

23 POK 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)4153
20255119
20246161
20231268
20221169
20212162
20202143
20191128
20171103

Who submits

15 applicants cleared a POK device since 2011. 43% of the clearances went to applicants in United States, then France (26%), United Kingdom (17%) and Australia (4%). By type: Traditional 87%, Special 9% and Direct 4%.

ApplicantClearances since 2011
Koios Medical, Inc.4
Brightheart3
Brainomix Limited2
Ischemaview, Inc.2
Sonio2
Aisap1
Avenda Health, Inc.1
Avicenna.Ai1

What the special controls require

From the special controls in 21 CFR 892.2060(b)(1), which also set labeling requirements. Read the source.

  • A detailed description of the image analysis algorithms, their inputs and outputs, and their limitations
  • Pre-specified performance testing protocols and datasets that assess whether the device improves reader performance
  • Results showing improved reader performance in the intended use population, with diagnostic accuracy measures and enough cases per important cohort
  • Standalone performance testing protocols and results
  • Software documentation, including hazard analysis, traceability, verification and validation, and cybersecurity

Standards

21 CFR 892.2060 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent POK clearances declared.

POK is one of the product codes most common on FDA’s list of AI-enabled devices. See how FDA regulates AI-enabled medical devices.

Ask about POK

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about POK

What is FDA product code POK?

Product code POK covers computer-assisted diagnostic software for lesions suspicious for cancer, Class II devices regulated under 21 CFR 892.2060 and reviewed by FDA's Radiology panel. FDA's 510(k) database lists 24 clearances under POK.

How many 510(k) clearances are there under POK?

FDA’s 510(k) database listed 24 clearances under POK as of Nov 16, 2026, 23 of them decided since 2011; the most recent decision was Oct 23, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a POK 510(k)?

For the 11 POK clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 116 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most POK clearances?

Since 2011: Koios Medical, Inc. (4), Brightheart (3), Brainomix Limited (2), Ischemaview, Inc. (2) and Sonio (2). 15 applicants have cleared a POK device in that time.

What testing do POK submissions include?

From the special controls in 21 CFR 892.2060(b)(1), which also set labeling requirements. In short: a detailed description of the image analysis algorithms, their inputs and outputs, and their limitations; pre-specified performance testing protocols and datasets that assess whether the device improves reader performance; results showing improved reader performance in the intended use population, with diagnostic accuracy measures and enough cases per important cohort; standalone performance testing protocols and results; software documentation, including hazard analysis, traceability, verification and validation, and cybersecurity.

Sources

  1. FDA product classification: POK · Product Classification database
  2. 21 CFR 892.2060: Radiological computer-assisted diagnostic software for lesions suspicious of cancer · eCFR
  3. openFDA 510(k) query for POK · run Nov 16, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
  5. List of Artificial Intelligence-Enabled Medical Devices · FDA, content current as of Sep 4, 2026
Follow POKGet an email when FDA clears, recalls or publishes guidance for computer-assisted diagnostic software for lesions suspicious for cancer.

Know what FDA already cleared.